Eisai Inc. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...

The report identifies key market opportunities by providing insights into global clinical trials for Gaucher Disease, highlighting trends in trial enrollment, geographic hotspots, and prominent drugs ...

On 13 November 2025, Merck Sharp & Dohme LLC initiated a study is to learn if people who receive patritumab deruxtecan (also ...

The global bronchitis clinical trials landscape reveals opportunities in optimizing trial locations, enhancing enrollment strategies, and investing in promising drugs. By analyzing trial phases, ...

The leading Familial Chylomicronemia Syndrome Companies such as Ionis Pharmaceuticals, Pfizer, Arrowhead Pharmaceuticals, ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

The Electronic Data Capture Software Market is witnessing robust growth driven by the rising demand for decentralized clinical trials, real-time data monitoring, and compliance-friendly digital ...

Sino Biopharmaceutical ( ($HK:1177) ) has shared an update. Sino Biopharmaceutical Limited announced that its innovative drug, LM-350 ‘CDH17 ADC’, ...

Clinical success achieved with one or two doses of TARA-002 in 88% of patientsTARA-002 demonstrated favorable safety and ...

Orforglipron is a small‑molecule, nonpeptide GLP‑1 receptor agonist taken once daily, and it skips some of the hassles that ...

The review analyzes red meat's effects on inflammatory biomarkers, revealing significant associations with CRP in specific adult subgroups and dietary contexts.